INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026
Page 983 of 1737
← PrevNext →
Apr 10, 2026
traded Apr 7, 2026
+3d
SEC Form 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$934K
1,617 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

15
HJ
Hord Michael JosephChief Financial Officer
COOKTraeger, Inc.
Tax withholding
F$17K
548 sh
Apr 6, 2026Apr 10, 2026
traded Apr 6, 2026
+4dSEC Form 4

Evidence

14
TS
Tamari ShaharDirector, COO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$129K
4,007 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

14
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$129K
4,001 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
TE
Tan Hock EDirector, President and CEO
AVGOBroadcom Inc.
Gift
G—
22.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$103K
332 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Grant or award
A—
208 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
KP
Kennedy Susan PDirector, Chief Executive Officer
CDZICADIZ INC
Grant or award
A—
125.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
RC
Rivera CathrynChief Operating Officer
CDZICADIZ INC
Grant or award
A—
10.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
GA
Gonzalez Luis ADirector, 10% Owner
AVOMission Produce, Inc.
Tax withholding
F$48K
3,271 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

13
BJ
Barnard Stephen JDirector, Executive Chairman
AVOMission Produce, Inc.
Grant or award
A—
31.6K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

13
ML
Michaels Adam LauranceDirector, Chief Executive Officer
MAMAMama's Creations, Inc.
Grant or award
A—
97.5K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Grant or award
A—
170 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$106K
15.0K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Grant or award
A—
142 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
BG
Bright GuntherDirector
ALLYAlly Financial Inc.
Grant or award
A$14K
348 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$463K
3,200 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

13
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

12
SS
Sidhu Samvir S.Director, CEO
CUBICustomers Bancorp, Inc.
Tax withholding
F$115K
1,562 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

12
BJ
Beckelman JohnDirector
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise
M$104K
8,667 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

12
WJ
Walsh Jay JPresident, Franklin Fueling
FELEFRANKLIN ELECTRIC CO INC
Tax withholding
F$89K
894 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

12
TB
Tobey BruceGeneral Counsel
LIONLionsgate Studios Corp.
Tax withholding
F$122K
11.6K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$322K
560 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

11
BL
Brooks Jayme L.Chief Financial Officer
LMBLimbach Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$287K
3,366 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

11
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$659K
1,139 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

10
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$38K
5,420 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

9
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
TE
Trencher EliottEVP, Chief Investment Officer
NYSEKRCKILROY REALTY CORP
Grant or award
A—
430 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
TE
Trencher EliottEVP, Chief Investment Officer
NYSEKRCKILROY REALTY CORP
Grant or award
A—
403 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
AM
Aman Angela MDirector, Chief Executive Officer
NYSEKRCKILROY REALTY CORP
Grant or award
A—
1,456 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
SS
Schwartz Sherrie SageSee Remarks
NYSEKRCKILROY REALTY CORP
Grant or award
A—
89 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
KJ
Kuehling JeffreySee Remarks
NYSEKRCKILROY REALTY CORP
Grant or award
A—
244 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Grant or award
A—
231 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
KK
Korde KishoreEVP
ALSUMISHO AIR LEASE CORP
Disposition to issuer
D$13K
199 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
DS
Deppe Christopher S.Chief Financial Officer
CHWYChewy, Inc.
Grant or award
A—
5,922 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
RL
Ritter LouisaDirector
NYSEKRCKILROY REALTY CORP
Grant or award
A—
291 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
DS
Deppe Christopher S.Chief Financial Officer
CHWYChewy, Inc.
Grant or award
A—
71.1K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

9
PA
Pack Jay ADirector
AVOMission Produce, Inc.
Grant or award
A—
8,240 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence